Induction of partial epileptic seizures by flumazenil

Epilepsia

Volumn 41, Issue 2, 2000, Pages 186-192

  Schulze Bonhage, A ^a,b   Elger, C E ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Activation method; Benzodiazepine receptor antagonist; Epilepsy; Flumazenil; Presurgical monitoring

Indexed keywords

ALPRAZOLAM; CLOBAZAM; CLONAZEPAM; DIAZEPAM; FLUMAZENIL; LORAZEPAM;

ARTICLE; ELECTROENCEPHALOGRAPHY; FOCAL EPILEPSY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SEIZURE;

EID: 0033951415     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.2000.tb00138.x     Document Type: Article

References (63)

1. Miley CE, Forster FM. Activation of partial complex seizures by hyperventilation. Arch Neurol 1977;34:371-3.
2. Wilder BJ. EEG activation in medically intractable epileptic patients: activation techniques including surgical follow-up. Arch Neurol 1971;25:415-26.
3. Aasley J, Blom S, Silvenius H, Zetterlung B. Effects of amobarbital and methohexital on epileptic activity in mesial temporal structures in epileptic patients: an EEG study with depth electrodes. Acta Neurol Scand 1984;70:423-30.
4. Hufnagel A, Burr W, Elger CE, Nadstawek J, Hefner G. Localization of the epileptic focus during methohexital-induced anaesthesia. Epilepsia 1992;33:271-84.
5. Möhler H, Richards JG. Agonist and antagonist benzodiazepine receptor interaction in vitro. Nature 1981;294:763-5.
6. Hunkeler W, Möhler H, Pieri L, et al. Selective antagonists of benzodiazepines. Nature 1981;290:514-6.
7. Haefely W. The preclinical pharmacology of flumazenil. Eur J Anaesthesiol 1988;(suppl 2):25-36.
8. Krespan B, Springfield SA, Haas H, Geller HM. Electrophysiological studies on benzodiazepine antagonists. Brain Res 1984; 295:265-74.
9. - channels recorded from membrane patches of neonatal rat cortical neurons in culture. J Pharmacol Exp Ther 1987;243:1195-201.
10. Darragh A, Lambe R, Kenny M, Brick I. Tolerance of healthy volunteers to intravenous administration of the benzodiazepine antagonist Ro 15-1788. Eur J Clin Pharmacol 1984;24:569-70.
11. Albertson TE, Bowyer JF, Paule MG. Modification of the anticonvulsant efficacy of diazepam by Ro-15-1788 in the kindled amygdaloid seizure model. Life Sci 1982;31:1597-601.
12. Lukas SE, Griffiths RR. Precipitated withdrawal by a benzodiazepine receptor antagonist (Ro 15-1788) after 7 days of diazepam. Science 1982;217:1161-3.
13. Nutt DJ, Cowen PJ, Little HJ. Unusual interactions of benzodiazepine receptor antagonists. Nature 1982;295:436-8.
14. Cumin R, Bonetti EP, Scherschlicht R, Haefely WE. Use of the specific benzodiazepine antagonist, Ro 15-1788, in studies of physiological dependence on benzodiazepines. Experientia 1982; 38:833-4.
15. Bonetti EP, Pieri L, Cumin R, et al. Benzodiazepine antagonist Ro 15-1788: neurological and behavioral effects. Psychopharmacology 1982;78:8-18.
16. McNicholas LF, Martin WR. The effect of a benzodiazepine antagonist, Ro 15-1788, in diazepam dependent rats. Life Sci 1982; 31:731-7.
17. Le Gal la Salle G, Feldblum S. Reversal of the anticonvulsant effects of diazepam on amygdaloid-kindled seizures by a specific benzodiazepine antagonist: Ro 15-1788. Eur J Pharmacol 1983; 86:91-3.
18. Pedder SCJ, Wilcox R, Tuchek JM, Crawford RD, Johnson DD. Benzodiazepine antagonist Ro 15-1788 (flumazenil) attenuates the anticonvulsant activity of diazepam in epileptic fowl. Brain Res 1987;424:139-43.
19. Robertson HA, Riives ML. A benzodiazepine antagonist is an anticonvulsant in an animal model for limbic epilepsy. Brain Res 1983;270:380-2.
20. Wilson MA, Gallager DW. Ro 15-1788-induced seizures in rats continually exposed to diazepam for prolonged periods. Epilepsy Res 1988;2:14-9.
21. Peeters BWMM, Van Rijn CM, Nutt DJ, Titulaer MNG, Vossen JMH, Coenen AML. Diazepam and Ro 15-1788 increase absence epilepsy in WAG/Rij rats chronically exposed to diazepam. Eur J Pharmacol 1990;178:111-4.
22. Torchin CD, Kapetanovic IM, Kupferberg HJ. A system for testing the development and reversal of anticonvulsant tolerance to benzodiazepine in mice. Epilepsy Res 1993;16:27-35.
23. King GL, Knox JJ, Dingledine R. Reduction of inhibition by a benzodiazepine antagonists, Ro 15-1788, in the rat hippocampal slice. Neuroscience 1985;15:371-8.
24. Morin AM. Beta-carboline kindling of the benzodiazepine receptor. Brain Res 1984;321:151-4.
25. 1, receptor subtype, retards the development and expression of amygdaloid-kindled seizures: effects of flumazenil. Epilepsy Res 1993;16:19-26.
26. Greksch G, Cavalho L, Vanault P, Chapouthier G, Rossier J. Convulsions induced by submaximal dose of pentylenetetrazol in mice are antagonized by the benzodiazepine antagonist Ro 15-1788. Life Sci 1983;32:2579-84.
27. Jensen LH, Petersen EN, Braestrup C. Audiogenic seizures in DBA/2 mice discriminate sensitively between low efficacy benzodiazepine receptor agonists and inverse agonists. Life Sci 1983;33: 393-9.
28. Marescaux C, Micheletti G, Vergnes M, Depaulis A, Rumbach L, Warter J-M. Biphasic effects of Ro 15-1788 on spontaneous petit mal-like seizures in rats. Eur J Pharmacol 1984;102:355-9.
29. Rathouská J, Kubova H, Mares P, Vorlicek. Anticonvulsant activity of flumazenil in rats during ontogenetic development. Pharmacol Biochem Behav 1993;44:581-6.
30. Pole P, Jahromi SS, Facciponte G, Pelletier MR, Zhang L, Carlen PL. Benzodiazepine antagonists reduce epileptiform discharges in rat hippocampal slices. Epilepsia 1996;37:1007-14.
31. Alho H, Costa E, Ferrero P, Fujimoto M, Cosenza-Murphy D, Guidotti A. Diazepam-binding inhibitor: a neuropeptide located in selected neuronal populations of rat brain. Science 1985;229:179-82.
32. Haefely W. Partial agonists of the benzodiazepine receptor: from animal data to results in patients. In: Biggio G, Costa E, eds. Chloride channels and their modulation by neurotransmitters and drugs. New York: Raven Press, 1988:275-92.
33. Hart YM, Meinardi H, Sander JWAS, Nutt DJ, Shorvon SD. The effect of intravenous flumazenil on interictal electroencephalographic epileptic activity: results of a placebo-controlled study. J Neurol Neurosurg Psychiatry 1991;54:305-9.
34. Mordel A, Winkler E, Almog S, Tirosh M, Ezra D. Seizures after flumazenil administration in a case of combined benzodiazepine and tricyclic antidepressant overdose. Crit Care Med 1992;20: 1733-4.
35. Spivey WH. Flumazenil and seizures: analysis of 43 cases. Clin Ther 1992;14:292-305.
36. Thomas P, Lebrun C, Chatel M. De novo absence status epilepticus as a benzodiazepine withdrawal syndrome. Epilepsia 1993;34: 355-8.
37. Davis CO, Wax PM. Flumazenil associated seizure in an 11-month-old child. J Emerg Med 1996;14:331-3.
38. Chern TL, Kwan A. Flumazenil-induced seizure accompanying benzodiazepine and baclofen intoxication. Am J Emerg Med 1996; 14:231-2.
39. Scollo-Lavizzari G. The clinical anticonvulsant effects of flumazenil, a benzodiazepine antagonist. Eur J Anaesthesiol 1988;(suppl 2):129-38.
40. Savic I, Widén L, Stone-Elander S. Feasibility of reversing benzodiazepine tolerance with flumazenil. Lancet 1991;337:133-7.
41. Sharief MK, Sancer JWAS, Shorvon SD. The effect of oral flumazenil on interictal epileptic activity: results of a double-blind, placebo-controlled study. Epilepsy Res 1993;15:53-60.
42. Steinhoff BJ, Stodieck SRG. Temporary abolition of seizure activity by flumazenil in a case of valproate-induced nonconvulsive status epilepticus. Seizure 1993;2:261-5.
43. Reisner-Keller LA, Pham Z. Oral flumazenil in the treatment of epilepsy. Ann Pharmacother 1995;29:530-1.
44. Gallager DW, Heninger K, Heninger G. Periodic benzodiazepine antagonist administration prevents benzodiazepine withdrawal symptoms in primates. Eur J Pharmacol 1986;132:31-8.
45. 3H-1,5-benzodiazepines), a new psychotherapeutic agent. Arzneimittelforschung 1973;23:683-6.
46. Gastaut H, Low MD. Antiepileptic properties of clobazam, a 1,5-benzodiazepine, in man. Epilepsia 1979;20:437-46.
47. Shenoy AK, Miyahara JT, Swinyard EA, Kupferberg HJ. Comparative anticonvulsant activity and neurotoxicity of clobazam, diazepam, phenobarbital, and valproate in mice and rats. Epilepsia 1982;23:399-408.
48. Kruse HJ. Psychopharmacology of clobazam with special reference to its anticonvulsant activity. In: Hindmarck I, Stonier PD, and Trimble HR, eds. London, xx; 1985:113-20.
49. Koeppen D, Baruzzi A, Capozza M, et al. Clobazam in therapy-resistant patients with partial epilepsy: a double-blind placebo-controlled crossover study. Epilepsia 1987;28:495-506.
50. 11C Ro 15-1788 binding to the human neocortex using positron emission tomography. Hum Psychopharmacol 1989;4:21-31.
51. Amrein R, Leishman B, Bentzinger C. Roncari G. Flumazenil in benzodiazepine antagonism: actions and clinical use in intoxications and anaesthesiology. Med Toxicol 1987;2:411-29.
52. Dunton AW, Schwam E, Pitman V, McGrath J, Hendeler J, Siegel J. Flumazenil: US clinical pharmacology studies. Eur J Anaesthesiol 1988;suppl 2:81-95.
53. Amrein R, Hetzel W, Bonetti EP, Gerecke M. Clinical pharmacology of Dormicum (midazolam) and Anexate (flumazenil). Resuscitation 1988;16(suppl):S5-27.
54. Klotz U, Ziegler G, Reiman J. Pharmacokinetics of the selective benzodiazepine antagonist Ro 15-1788 in man. Eur J Clin Pharmacol 1984;27:115-7.
55. Nakamura F, Suzuki S, Nishimura S, Yagi K, Seino M. Effects of clobazam and its active metabolite on GABA-activated currents in rat cerebral neurons in culture. Epilepsia 1996;37:728-35.
56. Wieser HG, Bancaud J, Talairach J. Bonis A, Szikla G. Comparative value of spontaneous and chemically and electrically induced seizures in establishing the lateralization of temporal lobe seizures. Epilepsia 1979;20:47-59.
57. Engel J, Crandall P. Falsely localizing ictal onsets with depth EEG telemetry during anticonvulsant withdrawal. Epilepsia 1983;24: 344-55.
58. Marks DA, Katz A, Scheyer R, Spencer SS. Clinical and electrographic effects of acute anticonvulsant withdrawal in epileptic patients. Neurology 1991;41:508-12.
59. Lhereux P, Askenasi R. Double-blind study of Anexate™ in benzodiazepine intoxication. Eur J Anaesthesiol 1988;(suppl 2): 300-4.
60. Burr W, Sandham P, Judd A. Death after flumazenil. BMJ 1989; 298:1713.
61. Lukas SE, Griffiths RR. Precipitated diazepam withdrawal in baboons: effects of dose and duration of diazepam exposure. Eur J Pharmacol 1984;100:163-71.
62. Gotman J, Marciani MG. Electroencephalographic spiking activity, drug levels, and seizure occurrence in epileptic patients. Ann Neurol 1985;17:597-603.
63. Milligan N, Dhillon S, Oxley J, Richens A. Absorption of diazepam from the rectum and its effect on interictal spikes in the EEG. Epilepsia 1982;23:323-31.